IRM vs PTGX · P/E 136, rev $3.97B vs rev $269.8M
Iron Mountain Incorporated (IRM) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the IRM and PTGX stock pages for the full models.
Not investment advice.